1. Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview;Chen;Med. Sci. Mon. Int. Med. J. Exp. Clin. Res.,2016
2. Molybdenum cofactors, enzymes and pathways;Schwarz;Nature,2009
3. Role of uric acid metabolism-related inflammation in the pathogenesis of metabolic syndrome components such as atherosclerosis and nonalcoholic steatohepatitis;Kushiyama;Mediat. Inflamm.,2016
4. Soluble uric acid activates the NLRP3 inflammasome;Braga;Sci. Rep.,2017
5. The crystallization of monosodium urate;Martillo;Curr. Rheumatol. Rep.,2014